Blocking immunosuppressive neutrophils deters pY696-EZH2–driven brain metastases

Xiangliang YUAN, PostDoc Fellow, PhD, University of Texas MD Anderson Cancer Center, Texas, MD Anderson, Department of Molecular and Cellular Oncology

Type I interferon response in astrocytes promotes brain metastasis by enhancing monocytic myeloid cell recruitment

Blocking immunosuppressive neutrophils deters pY696-EZH2–driven brain metastases

Current landscape and challenges ahead of immuno-molecular mechanism and immunotherapy strategy of brain metastases

PDF) Emerging principles of brain immunology and immune checkpoint blockade in brain metastases

Biomedicines, Free Full-Text

Local, multimodal intralesional therapy renders distant brain metastases susceptible to PD-L1 blockade in a preclinical model of triple-negative breast cancer

EZH2 engages TGFβ signaling to promote breast cancer bone metastasis via integrin β1-FAK activation

Frontiers The progress of microenvironment-targeted therapies in brain metastases

BHLHE22 drives the immunosuppressive bone tumor microenvironment and associated bone metastasis in prostate cancer

Exosomal miR-4466 from nicotine-activated neutrophils promotes tumor cell stemness and metabolism in lung cancer metastasis

Exosomal miR-4466 from nicotine-activated neutrophils promotes tumor cell stemness and metabolism in lung cancer metastasis

Immunosuppressive reprogramming of neutrophils by lung mesenchymal cells promotes breast cancer metastasis

Blocking immunosuppressive neutrophils deters pY696-EZH2–driven brain metastases